Team Diaton Tonometer at the Collaborative Community on Ophthalmic Innovation (CCOI) Meeting

NEW YORK - Jan. 28, 2025 - PRLog -- Team Diaton Highlights Groundbreaking Advancements at the Collaborative Community on Ophthalmic Innovation (CCOI) Meeting

January 2025 – Team Diaton proudly presented its revolutionary transpalpebral and transscleral tonometer at the Collaborative Community on Ophthalmic Innovation (CCOI) meeting, showcasing its potential to redefine ocular health diagnostics and inspire innovations across medical fields.

The Diaton tonometer offers a unique, non-invasive approach to intraocular pressure (IOP) measurement by bypassing the cornea entirely. Its transpalpebral method ensures accuracy and safety, even in complex cases such as patients with Boston KPro Type 1 Keratoprosthesis, where traditional devices fail. Diaton's ability to measure IOP without corneal contact also enhances its compatibility with advanced technologies like smart contact lenses and scleral lenses, supporting both patient safety and manufacturing advancements.

Additionally, the device's versatility extends beyond ophthalmology, as evidenced by its use in a groundbreaking UCLA study for non-invasive intracranial pressure monitoring. This highlights Diaton's potential to address critical challenges in neurology and critical care.

Team Diaton emphasized how this cutting-edge technology aligns with key themes discussed at the CCOI meeting, including AI integration, vision restoration, and advanced ocular devices. Its ability to provide accurate, cornea-independent readings makes it a vital tool for researchers, clinicians, and innovators globally.

For more information about Diaton tonometer and its contributions to ophthalmic innovation, visit tonometerdiaton.com.